The world over, there is increased interest in the possibility of extending human longevity. What could our lives look like if we had more control over our cells? If we had more control over disease? The potential is forever captivating.

That potential is the leading driver of investment in anti-aging technology companies.

As technology advances, people are expanding their understanding of what anti-aging breakthroughs will look like in the future. More than a “fountain of youth,” anti-aging technology holds the power to rejuvenate cells, treat chronic illnesses, even reverse blindness.

Alongside this increased interest in anti-aging technology is a desire to be a part of something greater, an urge to witness advancements that benefit humankind, and a search for treatments that address real needs that exist right now. It’s why investment in anti-aging companies and other biotech firms is soaring at a rapid clip: people want the chance to not only improve their own lives through material appreciation, but they also believe that investing in the science will open the door to huge breakthroughs down the road. These breakthroughs simply aren’t possible without dedicated investors.

Market Growth and Potential

From Main Street to Wall Street to the rarefied estates of Silicon Valley, investors are increasingly looking to pursue solutions to chronic illness, aging, and human frailty. As a result, the demand for viable biotech stocks is surging – and market growth is expected to surge in tandem as new treatments are developed that can change the game.

Broadly, the global anti-aging market is expected to grow to $64 billion in four short years, with a CAGR of 6.1% — despite the pandemic’s impact on the overall health care industry. With increased numbers of the elderly and rising disposable income globally, there is a huge appetite for anti-aging products that can address the physiological changes and challenges that occur as our bodies grow older.

As investors cast their nets wide to search for the best anti-aging technology companies to invest in, there’s no better time to support the incredible research happening at ProtoKinetix.

Enter ProtoKinetix: Anti-Aging Breakthroughs

ProtoKinetix (PKTX) is an R&D biotech company leading the way with antifreeze protection technology, including AAGP®, its patented polypeptide.

Based on the proteins that keep arctic fish from freezing, AAGP® is a highly bioavailable molecule found to protect against inflammation and keep cells alive. Think of it as the animal version of anti-freeze. But unlike those animal proteins found in nature, AAGP® was developed by ProtoKinetix to be stable and cost-effective — launching a thousand possibilities when it comes to human cells.

Led by a team of world-class scientists, ProtoKinetix has a number of solutions currently in development in pre-clinical and Phase 1 trials, including regenerative medicine and treatments in ophthalmology, dermatology, and transplants. This research pipeline has been in effect since 2005, backed by years of promising results and secured with patents for anti-aging technology.

Imagine the possibilities — we have.

From overcoming blindness to creating anti-aging skincare to improving the success rates of retinal transplants, the impact of ProtoKinetix’s potential cures is more than just financial — it’s lifechanging.

How might regenerative medicine move forward when it comes to Type II diabetes? Or heart health? Or macular degeneration? With the ability to physically preserve and even restore cells from the damage, the possibilities seem limitless. That’s the power of AAGP®.

Investing in the Future of Regenerative Medicine

When it comes to cellular regeneration and rejuvenation, science has only broached the very tip of the iceberg. As researchers explore the capabilities of AAGP® and other anti-aging technologies, the health therapies that will be developed will serve to make treatments more accessible for more people.

As it stands, the anti-aging market could top $420 billion by 2030. What sort of market growth could you expect if you held the cure to blindness? For that matter, what price can be put on restored vision — or on a healed heart, or an end to debilitating skin conditions?

But it’s not just billionaires who are seeking to invest in anti-aging technology, although the topic seems to draw an outsized share of their attention. No, the future of this science is one we all have a stake in. Everyone with a human body, and all its attendant complexities, stands to benefit. When we get closer to cures for diseases such as macular degeneration and diabetes, even stroke, we get closer to improving lives, and providing treatments that make a real difference.

World-Class Research, World-Class Leadership

The best anti-aging company to invest in is one that can go the distance. At ProtoKinetix, our leadership team has a clear vision for the future, a drive for debt-free operations and a commitment to revolutionizing the future of biomanufacturing.

With decades of experience in corporate management, pharmacology and scientific research, they are dedicated to fulfilling their mission to change lives for the better through effective, efficient leadership.

Our work can help make significant advances in anti-aging technology and bring us all closer to lifechanging developments. With your investment, we can get there faster.

Get in Touch

Invest in ProtoKinetix and own the future of anti-aging technology. Contact us to learn how.